GCP
HOOK

GSA Capital Partners’s HOOKIPA Pharma HOOK Stock Holding History

GSA Capital Partners’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-16,609
Closed -$71K – 1773
2024
Q3 		$71K Buy
16,609
+4,645
+39% +$24.5K 0.01% 1508
2024
Q2 		$71K Buy
+11,964
New +$94.9K 0.01% 1552
2022
Q2 		– Sell
-7,788
Closed -$178K – 1568
2022
Q1 		$178K Buy
7,788
+4,315
+124% +$77.3K 0.02% 1201
2021
Q4 		$81K Buy
+3,473
New +$140K 0.01% 1325

Other funds holding HOOK

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

GSA Capital Partners's HOOK Position: Q4 2024 in Review

GSA Capital Partners sold out of HOOKIPA Pharma (HOOK) in Q4 2024, closing a stake of 16,609 shares — an estimated $71K sold.

GSA Capital Partners first reported a position in HOOK in Q4 2021 and held it in 4 quarters. The position peaked at $178K in Q1 2022. 38 funds tracked by Wall St. Rank hold HOOK as of Q4 2024.

  • GSA Capital Partners reported no remaining HOOKIPA Pharma position as of Q4 2024 after selling out during the quarter.
  • GSA Capital Partners sold 16,609 HOOKIPA Pharma shares in Q4 2024, an estimated $71K.
  • GSA Capital Partners first reported a position in HOOKIPA Pharma in Q4 2021 and held it in 4 quarters.
  • GSA Capital Partners's HOOKIPA Pharma position peaked at $178K in Q1 2022.
  • 38 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q4 2024.

Based on GSA Capital Partners's 13F filing for Q4 2024, filed 7 Feb 2025.